Maxigen Biotech, Inc. engages in the business of collagen purification; research and development, production, and selling implantable medical device; and producing, manufacturing, wholesaling, and retailing cosmetics. It operates through the following segments: Biomedical Products, Consumer Products, and Others. The Biomedical Products segment includes manufacturing and selling collagen and bone materials. The Consumer Products segment focuses on beauty care products. The company was founded on December 3, 1998 and is headquartered in Taoyuan, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company